MX2009003002A - Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco. - Google Patents
Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco.Info
- Publication number
- MX2009003002A MX2009003002A MX2009003002A MX2009003002A MX2009003002A MX 2009003002 A MX2009003002 A MX 2009003002A MX 2009003002 A MX2009003002 A MX 2009003002A MX 2009003002 A MX2009003002 A MX 2009003002A MX 2009003002 A MX2009003002 A MX 2009003002A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- mucus clearance
- pulmonary surfactant
- pulmonary
- surfactant formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Abstract
Se describen métodos y composiciones para incrementar la aclaración del moco y para tratar las afecciones pulmonares del pulmón tales como fibrosis quística. Los métodos utilizan tensioactivos pulmonares, solos o combinados con agentes hiperosmóticos, administrados a los pacientes en una cantidad efectiva para incrementar la aclaración del moco. Las composiciones comprenden un tensioactivo pulmonar combinado con un agente activo osmóticamente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84599106P | 2006-09-19 | 2006-09-19 | |
PCT/US2007/020260 WO2008036293A1 (en) | 2006-09-19 | 2007-09-19 | Pulmonary surfactant formulations and methods for promoting mucus clearance |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009003002A true MX2009003002A (es) | 2009-06-01 |
Family
ID=38921793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009003002A MX2009003002A (es) | 2006-09-19 | 2007-09-19 | Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco. |
Country Status (11)
Country | Link |
---|---|
US (1) | US8221772B2 (es) |
EP (1) | EP2063903A1 (es) |
JP (1) | JP2010503731A (es) |
KR (1) | KR20090060348A (es) |
AU (1) | AU2007297691B2 (es) |
BR (1) | BRPI0717177A2 (es) |
CA (1) | CA2663795A1 (es) |
MX (1) | MX2009003002A (es) |
RU (1) | RU2455021C2 (es) |
WO (1) | WO2008036293A1 (es) |
ZA (1) | ZA200902487B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8669418B2 (en) | 2005-12-22 | 2014-03-11 | Vib Vzw | Means and methods for mediating protein interference |
WO2009049159A1 (en) | 2007-10-10 | 2009-04-16 | Parion Sciences, Inc. | Delivering osmolytes by nasal cannula |
CN102695525B (zh) * | 2009-07-31 | 2016-01-20 | 埃泽瑞斯公司 | 用于蛋白质表达的具有未修饰和修饰核苷酸的组合的rna |
EP2608769B1 (en) * | 2010-08-23 | 2019-11-06 | Fraunhofer Gesellschaft zur Förderung der Angewand | Humidified particles comprising a therapeutically active substance |
WO2012170677A1 (en) * | 2011-06-07 | 2012-12-13 | Parion Sciences, Inc. | Methods of treatment |
US8945605B2 (en) | 2011-06-07 | 2015-02-03 | Parion Sciences, Inc. | Aerosol delivery systems, compositions and methods |
WO2015061412A1 (en) * | 2013-10-22 | 2015-04-30 | The Scripps Research Institute | Methods and compositions for promoting bronchioli dilatation |
GB201406225D0 (en) * | 2014-04-07 | 2014-05-21 | Hall Roderick L | Treatment for respiratory disease |
US20170182063A1 (en) * | 2014-08-08 | 2017-06-29 | Shenzhen Hightide Biopharmaceutical, Ltd | Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof |
WO2017205383A1 (en) * | 2016-05-23 | 2017-11-30 | University Of Iowa Research Foundation | Method of treating cystic fibrosis airway disease |
WO2018017434A1 (en) * | 2016-07-16 | 2018-01-25 | Burch Lauranell Harrison | Methods for treating cystic fibrosis and other diseases affecting mucosal surfaces |
US11096932B2 (en) | 2016-09-29 | 2021-08-24 | The Uab Research Foundation | Methods and compositions for increasing mucus clearance |
US11872262B2 (en) | 2017-05-09 | 2024-01-16 | Vib Vzw | Means and methods for treating bacterial infections |
AU2018392461A1 (en) * | 2017-12-21 | 2020-07-02 | Civitas Therapeutics, Inc. | Surfactant formulations for inhalation |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840527A (en) * | 1984-12-11 | 1998-11-24 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Recombinant alveolar surfactant protein |
US4659805A (en) | 1984-12-11 | 1987-04-21 | California Biotechnology, Inc. | Recombinant alveolar surfactant protein |
US4918161A (en) * | 1985-09-26 | 1990-04-17 | Genetics Institute, Inc. | Low molecular weight pulmonary surfactant proteins |
IT1203873B (it) * | 1987-04-08 | 1989-02-23 | Chiesi Farma Spa | Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e |
AU625394B2 (en) | 1987-11-04 | 1992-07-09 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Alveolar surfactant proteins |
US6013619A (en) * | 1988-01-06 | 2000-01-11 | The Scripps Research Institute | Pulmonary surfactants and therapeutic uses, including pulmonary lavage |
US6613734B2 (en) * | 1988-01-06 | 2003-09-02 | The Scripps Research Institute | Peptides-containing liposomal surfactants |
US5164369A (en) | 1988-01-06 | 1992-11-17 | The Scripps Research Institute | Pulmonary surfactant protein and related polypeptide |
US5260273A (en) * | 1988-01-06 | 1993-11-09 | The Scripps Research Institute | Pulmonary surfactant protein and related polypeptide |
US4861756A (en) * | 1988-03-08 | 1989-08-29 | Merrell Dow Pharmaceuticals Inc. | Synthetic pulmonary surfactant |
SE8803713D0 (sv) * | 1988-10-18 | 1988-10-18 | Kabigen Ab | Biologically active lipoprotein and its use |
US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
US5238920A (en) * | 1989-08-22 | 1993-08-24 | Abbott Laboratories | Pulmonary surfactant protein fragments |
EP0458167B1 (en) * | 1990-05-21 | 1997-04-23 | Abbott Laboratories | Fatty acid-pulmonary surfactant conjugates |
US5272252A (en) * | 1991-11-04 | 1993-12-21 | Merrell Dow Pharmaceuticals Inc. | Synthetic lung surfactant having antioxidant properties |
EP0635028B1 (en) * | 1992-04-10 | 2003-01-22 | Abbott Laboratories | Pulmonary surfactant protein fragments |
US5302481A (en) * | 1993-06-07 | 1994-04-12 | Xerox Corporation | Toner compositions with negative charge enhancing complexes |
EP0733645B1 (en) * | 1993-12-08 | 2003-03-19 | Mitsubishi Pharma Corporation | Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome |
DE4418936A1 (de) * | 1994-05-31 | 1996-02-08 | Byk Gulden Lomberg Chem Fab | Polypeptid |
DE4434629C1 (de) * | 1994-09-28 | 1996-06-27 | Byk Gulden Lomberg Chem Fab | Zusammensetzungen zur Behandlung von IRDS und ARDS |
US5508269A (en) * | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
US5767068A (en) * | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
US5925334A (en) * | 1997-08-27 | 1999-07-20 | Rubin; Bruce K. | Use of surface active agents to promote mucus clearance |
US7198635B2 (en) * | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US6926911B1 (en) * | 1998-12-22 | 2005-08-09 | The University Of North Carolina At Chapel Hill | Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
DE69912988T2 (de) * | 1998-12-22 | 2004-11-11 | Bayer Ag | Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate |
RU2149014C1 (ru) | 1999-07-01 | 2000-05-20 | Центральный научно-исследовательский рентгенорадиологический институт | Способ лечения острых бронхопневмоний, осложненных ателектазом |
RU2149015C1 (ru) * | 1999-07-01 | 2000-05-20 | Центральный научно-исследовательский рентгенорадиологический институт | Способ лечения постнатальных пневмоний у новорожденных |
DE10006179A1 (de) | 2000-02-11 | 2001-08-23 | Byk Gulden Lomberg Chem Fab | Neue Verwendung von Lungensurfactant zur Prophylaxe und Behandlung von chronischen Lungenerkrankungen |
US6660833B1 (en) * | 2000-02-29 | 2003-12-09 | Harbor-Ucla Research And Education Institute | Respiratory distress syndrome therapy with peptide analogs of human SP-B |
MXPA02001323A (es) * | 2000-05-10 | 2004-07-16 | Alliance Pharma | Microgranulos con base fosfolipida para la liberacion de farmaco. |
US7422743B2 (en) * | 2000-05-10 | 2008-09-09 | Schering Corporation | Mammalian receptor protein DCRS5;methods of treatment |
ATE255929T1 (de) * | 2001-03-05 | 2003-12-15 | Ivo Pera | Inhalationsvorrichtung zum dispergieren von in kapseln enthaltenen pulverförmigen medikamente durch den respirationstrakt |
WO2002092154A1 (en) * | 2001-04-26 | 2002-11-21 | New England Pharmaceuticals, Inc. | Metered dose delivery device for liquid and powder agents |
RU2213746C1 (ru) | 2002-02-15 | 2003-10-10 | Научно-исследовательский институт физико-химической медицины | Компонент, обеспечивающий поверхностно-активные свойства композиций - аналогов препаратов для заместительной сурфактантной терапии легочных заболеваний |
RU2198670C1 (ru) | 2002-02-19 | 2003-02-20 | ООО "Биосурф" | Способ получения сурфактанта из легких крупного рогатого скота |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
AU2004296206A1 (en) * | 2003-12-04 | 2005-06-23 | The Scripps Research Institute | Treatment and preventions of asthma |
WO2005115520A1 (en) * | 2004-05-20 | 2005-12-08 | Discovery Laboratories, Inc. | Methods , systems and devices for noninvasive pulmonary delivery |
WO2006013183A1 (en) * | 2004-08-06 | 2006-02-09 | Altana Pharma Ag | Composition comprising a pulmonary surfactant and a tnf-derived peptide |
JP2008511398A (ja) | 2004-08-27 | 2008-04-17 | ディスカバリー ラボラトリーズ,インコーポレイテッド | 非侵襲性肺送出のための方法、システム及び装置 |
US7582312B2 (en) * | 2004-11-15 | 2009-09-01 | Discovery Laboratories, Inc. | Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
US8337815B2 (en) | 2004-12-23 | 2012-12-25 | Discovery Laboratories, Inc. | Pulmonary surfactant formulations |
EP2298349A1 (en) * | 2005-01-06 | 2011-03-23 | Discovery Laboratories, Inc. | Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia |
-
2007
- 2007-09-19 CA CA002663795A patent/CA2663795A1/en not_active Abandoned
- 2007-09-19 RU RU2009114825/15A patent/RU2455021C2/ru not_active IP Right Cessation
- 2007-09-19 AU AU2007297691A patent/AU2007297691B2/en not_active Ceased
- 2007-09-19 BR BRPI0717177-3A patent/BRPI0717177A2/pt not_active IP Right Cessation
- 2007-09-19 EP EP07838467A patent/EP2063903A1/en not_active Withdrawn
- 2007-09-19 ZA ZA200902487A patent/ZA200902487B/xx unknown
- 2007-09-19 KR KR1020097007998A patent/KR20090060348A/ko not_active Application Discontinuation
- 2007-09-19 US US11/901,866 patent/US8221772B2/en active Active
- 2007-09-19 JP JP2009529215A patent/JP2010503731A/ja active Pending
- 2007-09-19 MX MX2009003002A patent/MX2009003002A/es active IP Right Grant
- 2007-09-19 WO PCT/US2007/020260 patent/WO2008036293A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
KR20090060348A (ko) | 2009-06-11 |
WO2008036293A1 (en) | 2008-03-27 |
US8221772B2 (en) | 2012-07-17 |
CA2663795A1 (en) | 2008-03-27 |
EP2063903A1 (en) | 2009-06-03 |
JP2010503731A (ja) | 2010-02-04 |
US20080199410A1 (en) | 2008-08-21 |
ZA200902487B (en) | 2010-07-28 |
BRPI0717177A2 (pt) | 2013-10-08 |
AU2007297691B2 (en) | 2013-12-19 |
AU2007297691A1 (en) | 2008-03-27 |
RU2009114825A (ru) | 2010-10-27 |
RU2455021C2 (ru) | 2012-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009003002A (es) | Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco. | |
NO20090068L (no) | Aktive agent formuleringer, fremstillingsmetoder, og anvendelsesmetoder | |
WO2006089114A3 (en) | Methods and compositions for treating an anthrax toxin mediated condition | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
WO2007125545A3 (en) | Transmucosal composition | |
PE20080658A1 (es) | Formulaciones de metilnaltrexona en forma de polvo seco | |
CL2012000446A1 (es) | Uso de una formulación vesicular tópica que comprende uno o más fosfolípidos y uno o más tensoactivos en una razón molar de 1:1 a 25:1 de fosfolípidos a tensoactivos, para el tratamiento de trastornos dermatosos inflamatorios. | |
CR10408A (es) | Composiciones novedosas para el trastornos del cabello y procedimiento de preparacion de las mismas | |
WO2008151235A3 (en) | Compositions for delivering medicaments into the lungs, uses thereof | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
EA037285B8 (ru) | Липиды и композиции для доставки лекарственных средств | |
SI1933809T1 (sl) | Sestavki za mazalno dajanje | |
NO20060978L (no) | Farmasoytiske blandingr for behandling av prematur ejakulasjon ved pulmonal inhalering | |
CO6300964A2 (es) | Una composicion farmaceutica que comprende una combinacion de un agente quimioterapeutico y un anticuerpo 3 antiglipicano | |
MX2010004388A (es) | Formulaciones de hormona paratiroidea y usos de las mismas. | |
CR10495A (es) | Composicion que comprende por lo menos un alcohol alifatico superior y un extracto de griffonia simplicifolia | |
MX2012012355A (es) | Composiciones organicas para tratar enfermedades relacionadas con beta-enac. | |
WO2010068754A3 (en) | Methods and compositions for delivery of medicaments to the lungs | |
MX2009005798A (es) | Recuperacion de apoplejia. | |
TW200730190A (en) | New combination to treat liver fibrosis | |
WO2008099144A3 (en) | Tgf-beta stimulant and further agent to reduce side effects | |
WO2006033713A3 (en) | Methods for ciprofloxacin inhalation | |
IL186058A0 (en) | Polymorphs of 3-0-(3',3' -dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine salt | |
WO2007041388A3 (en) | Prevention and treatment of hearing disorders | |
WO2009000551A8 (de) | Verwendung einer synergistischen zusammensetzung als therapeutisches mittel oder desinfektionsmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |